“Key points Our results indicated that the combination of ellagic acid with erlotinib has synergistic effects against EGFR H773_V774 insH mutation.”
“Results EA was identified to synergistically inhibit the proliferation of Ba/F3‐insH cells with erlotinib.”
“The growth and clonogenic potential of Ba/F3‐insH cells were definitely constrained by EA with erlotinib , whereas, the apoptosis of Ba/F3‐insH cells was dramatically promoted by the combination.”